Superman can lift an elephant, but looks none too pleased about that on the cover of Action 630.
Owsley, Bright and Tanghal have Green Lantern and Captain Atom go head to head for much of this chapter.
It’s a big, but enjoyable, battle. Captain Atom comes out the winner, but it’d a moot point, as the alien promptly takes him down.
Wright, DuBurke and Marcos have Black Canary come to the rescue of the Deb at the start of this story. With people thinking she is a murderer, she is finding it hard to secure a heroin dealer. Canary saves her from some angry dealers, but the Deb gets away from Canary as well.
Some lovely art, and a far better story than the previous one, but still not quite up to par.
Pasko, Springer and McLaughlin bring the Secret Six saga to a conclusion in this issue, as the agency mounts their final attack on the group.
Carlo winds up getting killed in the battle, so the original team are all dead, as they were believed to be.
The new team disband at the end, although Mockingbird makes a final appearance, tagging a possible continuation. There never would be one.
Instead, the name Secret Six would come to be applied to other groups, the first of which being a team of heroes in the Tangent Universe.
Clark Kent is brought to the secret temple of the Superman worshippers, as the Superman worshippers haters approach. Superman determines that the powers they believe come from him really are coming from somewhere far away.
Speedy continues his team-up story single-handedly, thanks to Wilkerson and Mandrake.
Although he contacts the police about the fire-bombing, it turns out the police are in on it. The story does evoke some good paranoia, as he has no idea who to trust.
Blackhawk is summoned to see President Truman in this chapter, by Pasko, Burchett and Nyberg. Recruited into the CIA, they are given the mission to escort a shipment of LSD from the European manufacturer. At this point, it was considered a potential truth drug.
But the Nazis know what the CIA are up to, and the Nazi lady plans to disguise herself as an executive from the drug manufacturer.